Phase I and pharmacokinetic study of HGS-ETR2, a fully human agonistic monoclonal antibody to TRAIL-R2, in patients with advanced solid malignancies.

被引：0
|
作者：
Attard, G
Plummer, RE
De Bono, JS
Bale, C
Fong, P
Barrett, M
Fox, NL
Howard, T
Ullrich, S
Calvert, H
机构：
[1] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[2] No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
[3] Human Genome Sci, Rockville, MD USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9060S / 9060S
页数：1
相关论文
共 50 条
  • [31] Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies
    Athanassios Argiris
    Trevor M. Feinstein
    Lin Wang
    Tianbing Yang
    Shruti Agrawal
    Leonard J. Appleman
    Ronald G. Stoller
    Jennifer R. Grandis
    Ann Marie Egloff
    Investigational New Drugs, 2012, 30 : 1575 - 1584
  • [32] A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies
    Britten, CD
    Rowinsky, EK
    Baker, SD
    Agarwala, SS
    Eckardt, JR
    Barrington, R
    Diab, SG
    Hammond, LA
    Johnson, T
    Villalona-Calero, M
    Fraass, U
    Statkevich, P
    Von Hoff, DD
    Eckhardt, SG
    CLINICAL CANCER RESEARCH, 1999, 5 (07) : 1629 - 1637
  • [33] Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer
    Greco, F. Anthony
    Bonomi, Philip
    Crawford, Jeffrey
    Kelly, Karen
    Oh, Yun
    Halpern, Wendy
    Lo, Larry
    Gallant, Gilles
    Klein, Jerry
    LUNG CANCER, 2008, 61 (01) : 82 - 90
  • [34] HGS-ETR1, a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 1 (TRAIL-R1) in patients with advanced solid cancer: Results of a phase 1 trial.
    Hotte, SJ
    Hirte, HW
    Chen, EX
    Le, LH
    Corey, A
    Maclean, M
    Iacobucci, A
    Fox, NL
    Oza, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 204S - 204S
  • [35] The selective targeting of myeloid-derived suppressor cells in cancer patients using an agonistic TRAIL-R2 antibody
    Dominguez, George A.
    Condamine, Thomas
    Mony, Sridevi
    Hashimoto, Ayumi
    Wang, Fang
    Liu, Qin
    Forero, Andres
    Bendell, Johanna C.
    Witt, Robert
    Hockstein, Neil
    Kumar, Prasanna
    Gabrilovich, Dmitry I.
    CANCER RESEARCH, 2017, 77
  • [36] Phase I trial and pharmacokinetic study of Tanibirumab, a fully human monoclonal antibody to the vascular endothelial growth factor receptor 2 in patients with refractory solid tumors.
    Lee, Su Jin
    Ham, Jun Soo
    Kim, Hee Kyung
    Byeon, Seonggyu
    Lee, Seon Young
    Lee, Weon Sup
    Yoo, Jin San
    Sun, Jong Mu
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Ahn, Myung-Ju
    Lim, Ho Yeong
    Kang, Won Ki
    Park, Young Suk
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: A Phase I Study (vol 15, pg 5584, 2009)
    Mom, C. H.
    Verweij, J.
    Oldenhuis, C. N. A. M.
    CLINICAL CANCER RESEARCH, 2009, 15 (21) : 6744 - 6744
  • [38] Triggering of TRAIL-R1 and TRAIL-R2 death receptors by their selective fully human agonistic antibodies induces apoptosis in primary and cultured lymphoma cells
    Georgakis, G
    Li, Y
    Humphreys, R
    Andreeff, M
    O'Brien, S
    Younes, M
    Carbone, A
    Albert, V
    Younes, A
    ANNALS OF ONCOLOGY, 2005, 16 : 70 - 70
  • [39] A phase I and pharmacokinetic study of pemetrexed plus irinotecan in patients with advanced solid malignancies
    Rowinsky, Eric K.
    Beeram, Muralidhar
    Hammond, Lisa A.
    Schwartz, Garry
    De Bono, Johann
    Forouzesh, Baharam
    Chu, Quincy
    Latz, Jane E.
    Hong, Shengyan
    John, William
    Nguyen, Binh
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 532 - 539
  • [40] A Phase I and Pharmacokinetic Study of Ixabepilone in Combination with Carboplatin in Patients with Advanced Solid Malignancies
    Plummer, Ruth
    Woll, Penella
    Fyfe, David
    Boddy, Alan V.
    Griffin, Melanie
    Hewitt, Paula
    Carmichael, James
    Namouni, Fouad
    Cohen, Marvin
    Verrill, Mark
    CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8288 - 8294
12345